UBS Group’s Biolase, Inc. BIOL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-5,615
Closed -$6.3K 8846
2023
Q4
$6.3K Buy
+5,615
New +$6.3K ﹤0.01% 6503
2023
Q3
Sell
-407
Closed -$2.89K 8847
2023
Q2
$2.89K Buy
407
+371
+1,031% +$2.63K ﹤0.01% 6597
2023
Q1
$1.01K Buy
36
+19
+112% +$535 ﹤0.01% 7746
2022
Q4
$1.13K Sell
17
-39
-70% -$2.59K ﹤0.01% 8749
2022
Q3
$14K Buy
56
+51
+1,020% +$12.8K ﹤0.01% 6852
2022
Q2
$2K Buy
+5
New +$2K ﹤0.01% 8616
2022
Q1
Hold
0
9795
2021
Q4
Sell
-2
Closed -$4K 9543
2021
Q3
$4K Sell
2
-5
-71% -$10K ﹤0.01% 7557
2021
Q2
$13K Hold
7
﹤0.01% 6715
2021
Q1
$14K Buy
+7
New +$14K ﹤0.01% 6662
2020
Q4
Sell
-18
Closed -$13K 7719
2020
Q3
$13K Buy
18
+11
+157% +$7.94K ﹤0.01% 5783
2020
Q2
$8K Buy
7
+3
+75% +$3.43K ﹤0.01% 6306
2020
Q1
$4K Buy
+4
New +$4K ﹤0.01% 6500
2019
Q4
Sell
-4
Closed -$8K 7239
2019
Q3
$8K Hold
4
﹤0.01% 6330
2019
Q2
$14K Hold
4
﹤0.01% 5985
2019
Q1
$25K Buy
4
+2
+100% +$12.5K ﹤0.01% 5288
2018
Q4
$4K Hold
2
﹤0.01% 6720
2018
Q3
$9K Sell
2
-2
-50% -$9K ﹤0.01% 6302
2018
Q2
$13K Hold
4
﹤0.01% 6082
2018
Q1
$18K Buy
4
+2
+100% +$9K ﹤0.01% 5605
2017
Q4
$10K Sell
2
-2
-50% -$10K ﹤0.01% 6064
2017
Q3
$28K Buy
4
+2
+100% +$14K ﹤0.01% 5319
2017
Q2
$30K Buy
2
+1
+100% +$15K ﹤0.01% 5090
2017
Q1
$19K Sell
1
-1
-50% -$19K ﹤0.01% 5265
2016
Q4
$31K Buy
2
+1
+100% +$15.5K ﹤0.01% 5285
2016
Q3
$27K Hold
1
﹤0.01% 5160
2016
Q2
$15K Hold
1
﹤0.01% 5642
2016
Q1
$12K Hold
1
﹤0.01% 5704
2015
Q4
$11K Buy
+1
New +$11K ﹤0.01% 5964
2015
Q3
Hold
0
-$5K 6486
2015
Q2
Hold
0
-$7K 6299
2015
Q1
Hold
0
-$8K 6067
2014
Q4
Hold
0
6134